Tumor animal models can be divided into three categories: spontaneous tumor animal models, induced tumor animal model and animal models of transplantable tumors. The tumor-bearing mouse models that we can provide are mainly divided into two types. One is to inoculate human or mouse-derived cell lines into immunodeficient mice, called CDX models, and the other is to tumours derived from patients. Tissue pieces are inoculated into immunodeficient mice and are called PDX models.
Tumor cell tumor bearing model Sample requirements
Tumor cell tumor bearing model Experimental data
Hepatoma patient-derived xenograft model
PDX preserves the diversity of genotypes and phenotypes of the patient's tumor tissue, which truly reflects the characteristics of the original tumor;
PDX preserves tumor stromal cells and preserves tumor microenvironment;
Compared with tumor cell lines, the findings of PDX can more accurately reflect the tumorigenesis and development mechanism of patients.
Screening of anticancer drugs and development of biomarkers; collaborative clinical trials of oncology drugs; precision medicine; tumor mechanism.
Available PDX Services:
Self-produced immune-deficient M-NSGTM mice provide PDX transplant recipients; mature subcutaneous and organ inoculation techniques ensure F0 PDX construction and passage expansion; pathological and molecular biology techniques ensure PDX identification; cell culture techniques ensure long-term PDX Cryopreservation
Mature and reliable Search for Tumor Animal Models Solutions platform: rich project experience, participate in major projects, and publish high-level cooperation results.
The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible.
Creative Proteomics leads a rich team that uses the most rigorous experimental solutions and internationally recognized experimental techniques for Tumor Animal Models to obtain your customized information. Use the most accurate experimental results to help you better carry out tumor-related scientific research.
Please contact us to find out how we can help you achieve the next research breakthrough.